SODIUM NITROPRUSSIDE
Contract Overview
Solicitation details, issuing organization, response deadlines, documents, and interested companies for this government contract opportunity.
AI Contract Overview
Sodium Nitroprusside USP is a strictly regulated intravenous medication supplied as a 2 mL single-dose vial containing 50 mg of sodium nitroprusside dihydrate, equivalent to 25 mg per mL, intended exclusively for dilution and IV infusion—never for direct injection. It must be stored at controlled room temperature between 20°C and 25°C (68°F to 77°F), protected from light, and kept in its original carton until use. The product has a non-extendable shelf life of 24 months and is classified as a Type I (Code M) item under DLA shelf-life requirements. Labeling and packaging must strictly follow Medical Marking Standard No. 1, superseding MIL-STD-129, with all units sealed in suitable containers to prevent damage and shipped in commercial exterior packaging that ensures safe, cost-effective delivery to the destination. The item is regulated by the FDA and requires referral through EBS to the product specialist for buyer confirmation, including manufacturer and NDC details. Two approved manufacturers are identified: Medicure Pharma Inc with NDC 25208-0003-05 and Sagent Pharmaceuticals Inc with NDC 25021-0310-02. Packaging and shipping instructions align with commercial standards for hazardous materials, and delivery is FOB destination within 20 days of contract award. The contract references technical and quality requirements from the DLA Master List and includes transportation guidelines, special handling codes, and a designated government delivery point in APO AP 96543-4010, with the required delivery date set for July 21, 2026.
General Info
Agency
NAICS
Place of Performance
UNIT 14010 BOX, APO, AP, 96543-4010, USSet-Aside
Timeline
Response Deadline
Organization & Contact Information
Full Description
SODIUM NITROPRUSSIDE,USP
RA001: THIS DOCUMENT INCORPORATES TECHNICAL AND/OR QUALITY REQUIREMENTS
(IDENTIFIED BY AN 'R' OR AN 'I' NUMBER) SET FORTH IN FULL TEXT IN THE
DLA MASTER LIST OF TECHNICAL AND QUALITY REQUIREMENTS FOUND ON THE WEB
AT:
http://www.dla.mil/HQ/Acquisition/Offers/eProcurement.aspx http://www.dla.mil/HQ/Acquisition/Offers/eProcurement.aspx
FOR SIMPLIFIED ACQUISITIONS, THE REVISION OF THE MASTER IN EFFECT ON THE SOLICITATION ISSUE DATE OR THE AWARD DATE CONTROLS. FOR LARGE ACQUISITIONS, THE REVISION OF THE MASTER IN EFFECT ON THE RFP ISSUE DATE APPLIES UNLESS A SOLICITATION AMENDMENT INCORPORATES A FOLLOW-ON REVISION, IN WHICH CASE THE AMENDMENT DATE CONTROLS.
RP001: DLA PACKAGING REQUIREMENTS FOR PROCUREMENT
RQ011: REMOVAL OF GOVERNMENT IDENTIFICATION FROM NON-ACCEPTED SUPPLIES
. RX ONLY, FOR INTRAVENOUS INFUSION ONLY, NOT FOR DIRECT INJECTION. MUST
BE DILUTED. EACH 2 ML VIAL CONTAINS THE EQUIVALENT OF 50 MG SODIUM
NITROPRUSSIDE DIHYDRATE IN STERILE WATER FOR INJECTION. STRENGTH: 25 MG
PER ML. UNIT OF ISSUE IS A VIAL (SINGLE-DOSE FLIPTOP) CONTAINING 2 ML.
STORE AT 20° TO 25°C (68° TO 77°F) [SEE USP CONTROLLED ROOM
TEMPERATURE]. PROTECT FROM LIGHT AND STORE IN CARTON UNTIL IT IS USED.
LABELING AND MARKING MUST IN ACCORDANCE WITH MEDICAL MARKING STANDARD
NO. 1A DATED 4 FEBRUARY 2013. 9/14/2016.
This device or drug is regulated by the FDA. Note to Buyers: The contracting official shall send a referral in EBS to the product specialist for confirmation. Please include bidder name and bidder contact information, manufacturer name, manufacturer part number, and item description. RS016: Shelf-life requirement RS001 for a TYPE I (CODE M) item with a shelf life of 24 months (non-extendable) applies to this item.
APPLICABLE TO ALL MEDICAL ACQUISITIONS:
PACKAGING AND PACKING SHALL BE COMMERCIAL AS
SPECIFIED IN THE PROCUREMENT DOCUMENT.
EACH COMPLETE UNIT SHALL BE PROPERLY PACKAGED
IN A SUITABLE SEALED UNIT CONTAINER CAPABLE
OF PROTECTING THE CONTENTS FROM DAMAGE AND/OR
BREAKAGE.
UNITS SHALL BE PACKED IN SUITABLE COMMERCIAL
EXTERIOR (SHIPPING) CONTAINERS (EXPORT WHEN
NECESSARY) WHICH SHALL INSURE ACCEPTANCE AND
SAFE DELIVERY BY COMMON OR OTHER CARRIER, AT
THE LOWEST RATE, TO POINT OF DELIVERY CALLED
FOR IN THE CONTRACT OR ORDER.
MATERIAL MUST BE MARKED IAW MEDICAL MARKING
STANDARD NO. 1. THIS SUPERCEDES ALL REFERENCES
TO MIL-STD-129.
COPIES OF MEDICAL MARKING STANDARD NO. 1
(MMS NO. 1) MAY BE OBTAINED BY CONTACTING DLA
TROOP SUPPORT VIA EMAIL TO fssb@dla.mil. MMS NO. 1 IS ALSO AVAILABLE ONLINE AT:
SPE2DP-26-T-4194
SECTION B
https://www.dla.mil/Logistics-Operations/Packaging/
RD003, COVERED DEFENSE INFORMATION POTENTIALLY APPLIES
SHALL BE MARKED IAW THE LATEST EDITION OF
THE MEDICAL MARKING STANDARD NO. 1.
MMS NO. 1 IS AVAILABLE ONLINE AT:
https://www.dla.mil/Logistics-Operations/Packaging/
MEDICURE PHARMA INC 5EAC9 P/N NDC25208-0003-05 SAGENT PHARMACEUTICALS, INC 4RP13 P/N NDC25021-0310-02
DLA issues this document using the DoD authorized unit of issue, please refer to the following URL to determine the corresponding ANSI X12 unit of issue.
https://view.officeapps.live.com/op/view.aspx?src=https%3A%2F%2Fwww.dla.mil%2FPortals%2F104%2FDocuments% 2FDLMS%2FeApplications%2FLogDataAdmin%2FUnitofIssueandPurchaseUnit.xlsx&wdOrigin=BROWSELINK
CLIN PR PRLI UI QUANTITY UNIT PRICE TOTAL PRICE.
0001 7017526874 0001 VI 1.000
NSN/MATERIAL:6505016571391
DELIVERY (IN DAYS):0020
DELIVER FOB: DESTINATION
QTY VARIANCE: PLUS 0% MINUS 0%
INSPECTION POINT: DESTINATION
ACCEPTANCE POINT: DESTINATION
PREP FOR DELIVERY:
PKGING DATA MIL-STD-2073-1E
QUP:001 PRES MTHD:ZZ CLNG/DRY:Z PRESV MAT:ZZ
WRAP MAT:ZZ CUSH/DUNN MAT:ZZ CUSH/DUNN THKNESS:Z
UNIT CONT:ZZ OPI:A
INTRMDTE CONT:ZZ INTRMDTE CONT QTY:ZZZ
PACK CODE:Z PACKING LEVEL: B
MARKING SHALL BE IN ACCORDANCE WITH MIL-STD-129.
SPECIAL MARKING CODE:ZZ -ZZ Special Requirements
IP025: PACKAGING, MARKING, AND SHIPPING OF HAZARDOUS MATERIALS
APPLICABLE TO ALL MEDICAL ACQUISITIONS:
PACKAGING AND PACKING SHALL BE COMMERCIAL AS
SPECIFIED IN THE PROCUREMENT DOCUMENT.
EACH COMPLETE UNIT SHALL BE PROPERLY PACKAGED
IN A SUITABLE SEALED UNIT CONTAINER CAPABLE
OF PROTECTING THE CONTENTS FROM DAMAGE AND/OR
BREAKAGE.
UNITS SHALL BE PACKED IN SUITABLE COMMERCIAL
EXTERIOR (SHIPPING) CONTAINERS (EXPORT WHEN
SPE2DP-26-T-4194
SECTION B
PR: 7017526874 PRLI: 0001 CONT’D
NECESSARY) WHICH SHALL INSURE ACCEPTANCE AND
SAFE DELIVERY BY COMMON OR OTHER CARRIER, AT
THE LOWEST RATE, TO POINT OF DELIVERY CALLED
FOR IN THE CONTRACT OR ORDER.
MATERIAL MUST BE MARKED IAW MEDICAL MARKING
STANDARD NO. 1. THIS SUPERCEDES ALL REFERENCES
TO MIL-STD-129.
COPIES OF MEDICAL MARKING STANDARD NO. 1
(MMS NO. 1) MAY BE OBTAINED BY CONTACTING DLA
TROOP SUPPORT VIA EMAIL TO fssb@dla.mil. MMS NO. 1 IS ALSO AVAILABLE ONLINE AT: https://www.dla.mil/Logistics-Operations/Packaging/
PARCEL POST ADDRESS:
FY2915
FY2915 36 MDG SGSM
UNIT 14010 BOX
APO AP 96543-4010
US
FOR TRANSPORTATION SEE DLAD DLAD PROC NOTE C19. FOR FIRST DESTINATION TRANSPORTATION SEE DLAD PROC NOTE
C20 AND CONTRACT
FREIGHT SHIPPING ADDRESS:
FY2915
FY2915 36 MDG SGSM
CP 0116713665184
CAROLINES AVE BLDG 26001
JOINT REGION MARIANAS 96929
GU
M/F: (TCN) FM527061970066
RDD:
PROJ: TP 3
SUPP ADD: FY2915 SIG: J
FOR GOVERNMENT USE ONLY: (IPD) 12
DIC: A01 DIST: ADV: 2A FC: 6B
Need Ship Date:00/00/0000 Original Required Delivery Date:07/21/2026
SPE2DP-26-T-4194 NSN/Part Number: 6505-01-657-1391 Quantity: 1 VI Purchase Request: 7017526874QTY: 1 Delivery: 20 days ADO
Similar Contracts
Same NAICS industry code
More opportunities from Department Of Defense → MEDICAL SUPPLY CHAIN PHARM FSA
Same awarding agency
